At Cellebration, we have mastered the technology for isolating a maximum number of viable stem cells from either autologous (own) cells or allogeneic (donor) cells to treat patients with Crohn’s Disease. We isolate and enrich the viable cell stems which will be infused into the patient.
These cells are administered through one of two methods after a considerable analysis of the patient’s unique history.
Local Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Intravenous Administration
In this delivery mode, cells are infused into the peripheral veins to expand blood volumes in the system, to ensure that the maximum number of cells are reaching the targeted area.
Infused into the body, these cells can repopulate the damaged parts of the organ. Through paracrine effects, they differentiate into the damaged cells to restore function and continue to regulate the immune system and promote hormonal balance. Thus, with our highly specialized approach, it is now possible to obtain noticeable improvements in patients with Crohn’s Disease, for symptoms as well as improving functional abilities.